Tiffany Olson

Tiffany Olson has served as a member of the board of directors since May 2021. Since 2013, Ms. Olson has served as president of Nuclear & Precision Health Solutions at Cardinal Health, which develops, manufactures, compounds dispenses, and delivers 12 million time-critical, patient-specific doses annually to thousands of customers via a network of nuclear pharmacies and manufacturing sites that span the U.S. Prior to Cardinal Health, Ms. Olson was president of NaviMed, a company focused on personalizing medicine through innovative diagnostics. She also worked for Eli Lilly and Company, where she was tasked with leading the effort to formulate the strategy to create and commercialize diagnostics and companion diagnostics. Ms. Olson also worked for Roche Diagnostics, where she attained the position of president and chief executive officer of Roche Diagnostics Corporation. She was the first woman to receive the Life Science Alley Luminary Award, recognizing her “rich career in medical diagnostics…exceptional reputation as a leader and her vision to drive both innovation and value for personalized medicine.” Ms. Olson was recognized as one of the 10 Best Women Leaders of 2020 by the Industry Era. In 2013, she received the “Woman of Wellness Award” for her extraordinary contributions through her volunteer work in oncology. She currently serves as an ambassador with the American Cancer Society through the ResearcHERS: Women Fighting Cancer campaign, which helps fund women-led cancer research. She has written several articles on personalized medicine, molecular diagnostics, and business strategy. Ms. Olson has a bachelor’s degree in business from the University of Minnesota and a master’s degree from St. Thomas University in Minnesota. She has held several board positions and currently serves as a board member of the Council on Radionuclides and Radiopharmaceuticals, Inc. (CORAR).